SOUTHAMPTON, Pa., June 18 /PRNewswire-FirstCall/ -- Environmental Tectonics Corporation's (OTC Bulletin Board: ETCC) ("ETC" or the "Company") BioMedical Division today announced the sale of an additional BARA-MED(R)XD monoplace hyperbaric oxygen chamber to St. John Wound Center, Tulsa, Oklahoma, USA. The state-of-the-art monoplace chamber is among the first computer-controlled hyperbaric chambers to be placed into service in Oklahoma.

Hyperbaric chambers are used in Hyperbaric Oxygen Therapy (HBOT), which is a non-invasive procedure where the patient breathes 100% oxygen while fully enclosed in a specially designed chamber at increased atmospheric pressure. HBO is the primary treatment for carbon monoxide poisoning, arterial gas embolism and decompression sickness. It is also used to promote and support healing in the management of conditions in which oxygen transport to the tissues has been disrupted by traumatic injury, infection, inflammation, or edema.

St. John Health System operates hospitals in Tulsa, Owasso, Sapulpa and Bartlesville. A fifth affiliate hospital is under construction in Broken Arrow, Okla., with completion scheduled for 2010.

"The staff of the St. John Wound Center is committed to the treatment of the whole patient, not just the wound," said Dr. Lam Le, Medical Director of the St. John Wound Center. "We work closely with specialists and primary care physicians to provide a complete care plan for optimal wound healing to address the specific needs of each patient."

All ETC BioMedical monoplace chambers include O.S.C.A.R. (TM) (Operating System for Control And Recordkeeping), ETC's unique 4th generation, time-honored computerized operating system. O.S.C.A.R. includes a patient friendly pressurization alternative (Smooth Ride(TM)) that minimizes complications due to middle ear and sinus barotraumas without increasing compression time, programmable treatment protocols and more. As an added safety feature, ETC's chambers feature a full manual override system to avoid premature termination of treatment protocol as a result of power outages.

Gene Davis, President of ETC's BioMedical Division, commented, "Placement of the third chamber at this facility is a further indication that ETC chambers are in high demand for both quality and technology."

ETC is witnessing an increased demand from hospitals and wound care clinics that recognize President Obama's mandate for Electronic Medical Records (EMR). O.S.C.A.R. addresses this important initiative.

ETC was incorporated in 1969 in Pennsylvania and this year we will celebrate our 40th anniversary. Our core technologies include the design, manufacture and sale of Training Services (TSG) which includes (1) software driven products and services used to create and monitor the physiological effects of flight; (2) high performance jet tactical flight simulation; (3) driving and disaster simulation systems, and Control Systems (CSG) which includes: (1) steam and gas sterilization; (2) testing and simulation devices for the automotive industry; (3) hyperbaric and hypobaric chambers. Product categories included in TSG are Aircrew Training Systems (ATS) and flight simulators, disaster management systems and entertainment applications. CSG includes sterilizers, environmental control devices and hyperbaric chambers along with parts and service support.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on ETC's current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC and its subsidiaries that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

These forward-looking statements include statements with respect to the Company's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of the company, including but not limited to, (i) potential additional funding by H.F. Lenfest, a member of our Board of Directors and a significant shareholder and PNC Bank, (ii) the trading of the Company's common stock on the Over-the-Counter Bulletin Board (iii) projections of revenues, costs of materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (iv) statements of our plans and objectives of the Company or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (v) statements of future economic performance, (vi) statements of assumptions and other statements about the Company or its business, (vii) statements made about the possible outcomes of litigation involving the Company, (viii) statements regarding the Company's ability to obtain financing to support its operations and other expenses, and (ix) statements preceded by, followed by or that include the words, "may," "could," "should," "looking forward," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan," or the negative of such terms or similar expressions. These forward-looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in whole or in part, are beyond the Company's control. Factors that might cause or contribute to such a material difference include, but are not limited to, those discussed in the Company's Annual Report on Form 10K for the fiscal year ended February 27, 2009, in the section entitled "Risks Particular to Our Business." Shareholders are urged to review these risks carefully prior to making an investment in the Company's common stock.

The Company cautions that the foregoing list of important factors is not exclusive. Except as required by federal securities law, the Company does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

(Date:8/16/2017)... -- This year,s edition of the Inc. 5000 features a now-familiar name: BioPoint ... made the list for the third year in a row. Now in ... based on a set of quantitative metrics. In addition, BioPoint was also ... the Bay State . ... Inc. 5000 ...

(Date:8/15/2017)... ... 15, 2017 , ... The Conference Forum and The Trout ... a series of upcoming panels and events. The partnership culminates with the 4th ... in New York City. , “With our experience in producing the Immuno-Oncology 360° NYC ...

(Date:4/13/2017)... Calif. , April 13, 2017 UBM,s ... York will feature emerging and evolving technology ... Both Innovation Summits will run alongside the expo portion ... speaker sessions, panels and demonstrations focused on trending topics ... largest advanced design and manufacturing event will take place ...